Release Date: 06/01/09 17:31 Summary: Audited HY fin. statements of Matsuoka 30 June 2008 Price Sensitive: No Download Document 722.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%